Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VDet al.(2025) Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial J Clin Oncol, JCO2401386(in press) DOI 10.1200/JCO-24-01386, PubMed 40249893
Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Schönefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M(2025) Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia Leukemia(in press) DOI 10.1038/s41375-025-02577-8, PubMed 40234614
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH(2025) Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study Front Oncol, 15, 1595028 DOI 10.3389/fonc.2025.1595028, PubMed 40206591